Company · CIK 0001327467 · SIC 2834 — Pharmaceutical Preparations
Celator Pharmaceuticals Inc · CPXX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2016 UForm 4 → | Jul 12, 5:07 pm EDT | Bruce Kovner +2Other | 2,155,972 | $30.25 | $65,218,153 | 0 | — | plan? |
| Jul 12, 2016 DUForm 4 → | Jul 12, 5:04 pm EDT | Scott D MorensteinDirector | 1,045,386 | $30.25 | $31,622,927 | 0 | — | plan? |
| Jul 12, 2016 UForm 4 → | Jul 12, 5:00 pm EDT | Valence Life Sciences GP II LLC +2Other | 1,183,095 | $30.25 | $35,788,624 | 0 | — | plan? |
| Jul 12, 2016 DForm 4 → | Jul 12, 4:32 pm EDT | Nicole VitulloDirector | 2,401,524 | $30.25 | $72,646,101 | 0 | — | plan? |
| Jul 12, 2016 DForm 4 → | Jul 12, 4:24 pm EDT | Fred M PowellVP and Chief Financial Officer | 156,064 | $30.25 | $4,720,936 | 0 | — | plan? |
| Jul 12, 2016 DForm 4 → | Jul 12, 4:21 pm EDT | Scott Thomas JacksonChief Executive Officer, Director | 301,518 | $30.25 | $9,120,920 | 0 | — | plan? |
| Jul 12, 2016 DForm 4 → | Jul 12, 4:21 pm EDT | Lawrence David MayerSee Remarks | 118,614 | $30.25 | $3,588,074 | 0 | — | plan? |
| Jul 12, 2016 DForm 4 → | Jul 12, 4:18 pm EDT | Michael R DoughertyExecutive Chairman, Director | 20,000 | $30.25 | $605,000 | 0 | — | plan? |
| Jul 7, 2016 MForm 4 → | Jul 7, 6:02 pm EDT | Scott Thomas JacksonChief Executive Officer, Director | 251,475 | $2.84 | $714,147 | 301,518 | — | plan? |
| Jul 6, 2016 MForm 4 → | Jul 7, 6:02 pm EDT | Fred M PowellVP and Chief Financial Officer | 71,887 | $3.12 | $224,000 | 156,064 | — | plan? |
| Jun 29, 2016 GForm 4 → | Jul 1, 5:17 pm EDT | Fred M PowellVP and Chief Financial Officer | 1,665 | — | — | 84,177 | — | plan? |
| Jun 23, 2016 FMForm 4 → | Jun 27, 9:39 pm EDT | Fred M PowellSee Remarks | 59,366 | $2.53 | $150,179 | 85,842 | — | plan? |
| Jun 21, 2016 GForm 4 → | Jun 22, 3:16 pm EDT | Bruce Kovner +2Other | 1,218,941 | — | — | 1,591,750 | — | plan? |
| Jun 21, 2016 GForm 4 → | Jun 22, 2:33 pm EDT | Valence Life Sciences GP II LLC +2Other | 112,503 | — | — | 143,986 | — | plan? |
| Jun 20, 2016 UXForm 4 → | Jul 13, 1:06 pm EDT | Richard S KollenderDirector | 2,053,729 | $30.25 | $59,466,963 | 0 | — | plan? late |
| Mar 15, 2016 FMForm 4 → | Mar 17, 4:59 pm EDT | Lawrence David MayerPresident and Head of Research | 60,083 | $3.60 | $216,009 | 107,515 | — | plan? |
| Dec 3, 2015 PForm 4 → | Dec 7, 10:54 am EST | Scott D MorensteinDirector | 5,000 | $1.87 | $9,325 | 6,277 | +392% | plan? |
| Oct 6, 2015 PForm 4 → | Oct 7, 9:21 am EDT | Scott Thomas JacksonChief Executive Officer, Director | 14,450 | $1.74 | $25,143 | 50,043 | +40.6% | plan? |
| Oct 5, 2015 PForm 4 → | Oct 5, 4:05 pm EDT | Fred M PowellVP and Chief Financial Officer | 13,700 | $1.78 | $24,386 | 31,458 | +77.1% | plan? |
| Sep 30, 2015 PForm 4 → | Oct 2, 8:02 pm EDT | Valence Life Sciences GP II LLC +2Other | 12,200 | $1.64 | $20,054 | 171,986 | +7.64% | plan? |
| May 14, 2015 MForm 4 → | May 28, 4:01 pm EDT | Lawrence David MayerSee Remarks | 55,000 | $2.25 | $123,750 | 71,594 | — | plan? late |
| Feb 25, 2015 AForm 4/A → | Mar 2, 9:22 am EST | Lawrence David MayerPresident and Head of Research | 6,133 | — | — | 16,594 | — | plan? |
| Feb 25, 2015 AForm 4 → | Feb 27, 5:19 pm EST | Scott Thomas JacksonChief Executive Officer, Director | 22,593 | — | — | 35,593 | — | plan? |
| Feb 25, 2015 AForm 4 → | Feb 27, 5:17 pm EST | Fred M PowellChief Financial Officer | 6,758 | — | — | 17,758 | — | plan? |
| Feb 25, 2015 AForm 4 → | Feb 27, 5:14 pm EST | Lawrence David MayerPresident and Head of Research | 7,639 | — | — | 18,100 | — | plan? amended |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 12, 2016 JForm 4 → | Jul 12, 5:07 pm EDT | Bruce Kovner +2Other | 924,050 | — | — | 0 | — | |
| Jul 12, 2016 DUForm 4 → | Jul 12, 5:04 pm EDT | Scott D MorensteinDirector | 370,969 | $27.34 | $1,531,152 | 0 | — | |
| Jul 12, 2016 JForm 4 → | Jul 12, 5:00 pm EDT | Valence Life Sciences GP II LLC +2Other | 359,351 | — | — | 0 | — | |
| Jul 12, 2016 DForm 4 → | Jul 12, 4:32 pm EDT | Nicole VitulloDirector | 218,363 | — | — | 0 | — | |
| Jul 12, 2016 DForm 4 → | Jul 12, 4:23 pm EDT | Jean-Pierre BizzariDirector | 42,000 | $27.54 | $1,156,540 | 0 | — | |
| Jul 12, 2016 DForm 4 → | Jul 12, 4:21 pm EDT | Scott Thomas JacksonChief Executive Officer, Director | 1,177,968 | $27.86 | $32,813,478 | 0 | — | |
| Jul 12, 2016 DForm 4 → | Jul 12, 4:21 pm EDT | Joseph A MollicaDirector | 82,668 | $27.19 | $2,247,988 | 0 | — | |
| Jul 12, 2016 DForm 4 → | Jul 12, 4:21 pm EDT | Lawrence David MayerSee Remarks | 568,893 | $27.82 | $15,828,430 | 0 | — | |
| Jul 7, 2016 MForm 4 → | Jul 7, 6:02 pm EDT | Scott Thomas JacksonChief Executive Officer, Director | 251,475 | — | — | 333,724 | — | |
| Jul 6, 2016 DForm 4 → | Jul 12, 4:24 pm EDT | Fred M PowellVP and Chief Financial Officer | 423,613 | $27.75 | $11,753,995 | 0 | — | late |
| Jul 6, 2016 MForm 4 → | Jul 7, 6:02 pm EDT | Fred M PowellVP and Chief Financial Officer | 71,887 | — | — | 181,113 | — | |
| Jun 23, 2016 MForm 4 → | Jun 27, 9:39 pm EDT | Fred M PowellSee Remarks | 56,875 | — | — | 0 | — | |
| Jun 20, 2016 DXForm 4 → | Jul 13, 1:06 pm EDT | Richard S KollenderDirector | 181,771 | $26.65 | $2,128,526 | 0 | — | late |
| Mar 15, 2016 MForm 4 → | Mar 17, 4:59 pm EDT | Lawrence David MayerPresident and Head of Research | 48,002 | — | — | 0 | — | |
| Jan 27, 2016 DForm 4 → | Jul 12, 4:18 pm EDT | Michael R DoughertyExecutive Chairman, Director | 677,057 | $28.11 | $19,030,693 | 0 | — | late |
| Jan 27, 2016 AForm 4 → | Jan 29, 4:08 pm EST | Michael R DoughertyExecutive Chairman, Director | 92,457 | — | — | 17,457 | — | |
| Jan 27, 2016 AForm 4 → | Jan 29, 4:05 pm EST | Lawrence David MayerPresident & Chief Sci Officer | 210,677 | — | — | 35,677 | — | |
| Jan 27, 2016 AForm 4 → | Jan 29, 4:04 pm EST | Fred M PowellVice President and CFO | 194,375 | — | — | 56,875 | — | |
| Jan 27, 2016 AForm 4 → | Jan 29, 4:03 pm EST | Scott Thomas JacksonChief Executive Officer, Director | 413,835 | — | — | 118,835 | — | |
| Dec 2, 2015 PForm 4 → | Dec 4, 4:30 pm EST | Bruce Kovner +2Other | 73,452 | $0.24 | $17,628 | 889,403 | — | |
| Aug 20, 2015 AForm 4 → | Aug 24, 4:17 pm EDT | Michael R DoughertyExecutive Chairman, Director | 500,000 | — | — | 500,000 | — | |
| Jun 11, 2015 DForm 4 → | Jul 12, 2016, 4:22 pm EDT | Joseph M LobackiDirector | 56,000 | $27.17 | $1,521,240 | 0 | — | late |
| Jun 11, 2015 AForm 4 → | Jun 15, 4:17 pm EDT | Joseph A MollicaDirector | 14,000 | — | — | 14,000 | — | |
| Jun 11, 2015 AForm 4 → | Jun 15, 4:15 pm EDT | Joseph M LobackiDirector | 14,000 | — | — | 14,000 | — | |
| Jun 11, 2015 AForm 4 → | Jun 15, 4:11 pm EDT | Michael R DoughertyDirector | 22,000 | — | — | 22,000 | — | |
| Jun 11, 2015 AForm 4 → | Jun 15, 4:08 pm EDT | Jean-Pierre BizzariDirector | 14,000 | — | — | 14,000 | — | |
| Jun 11, 2015 AForm 4 → | Jun 15, 3:07 pm EDT | Richard S KollenderDirector | 14,000 | — | — | 14,000 | — | |
| Jun 11, 2015 AForm 4 → | Jun 15, 1:39 pm EDT | Scott D MorensteinDirector | 14,000 | — | — | 14,000 | — | |
| Jun 11, 2015 AForm 4 → | Jun 12, 8:48 am EDT | Nicole VitulloDirector | 14,000 | — | — | 14,000 | — | |
| May 14, 2015 MForm 4 → | May 28, 4:01 pm EDT | Lawrence David MayerSee Remarks | 55,000 | — | — | 7,829 | — | late |
| Feb 27, 2015 AForm 4 → | Mar 3, 5:06 pm EST | Jean-Pierre BizzariDirector | 28,000 | — | — | 28,000 | — | |
| Feb 25, 2015 AForm 4/A → | Mar 2, 9:22 am EST | Lawrence David MayerPresident and Head of Research | 80,000 | — | — | 80,000 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 5:19 pm EST | Scott Thomas JacksonChief Executive Officer, Director | 175,000 | — | — | 175,000 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 5:17 pm EST | Fred M PowellChief Financial Officer | 55,000 | — | — | 55,000 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 5:14 pm EST | Lawrence David MayerPresident and Head of Research | 80,000 | — | — | 80,000 | — | amended |